Calcium antagonists in secondary prevention: augmented proceedings of a symposium held in Stockholm, 21 September, 1990
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Auckland u.a.
Adis Internat.
1991
|
Schriftenreihe: | Drugs / Supplement
42,2 |
Schlagworte: | |
Beschreibung: | Literaturangaben |
Beschreibung: | 64 S. graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV004530608 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 910930s1991 d||| |||| 10||| eng d | ||
035 | |a (OCoLC)25176921 | ||
035 | |a (DE-599)BVBBV004530608 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-355 | ||
050 | 0 | |a RM666.C243 | |
245 | 1 | 0 | |a Calcium antagonists in secondary prevention |b augmented proceedings of a symposium held in Stockholm, 21 September, 1990 |c guest ed. D. T. Kelly ... |
264 | 1 | |a Auckland u.a. |b Adis Internat. |c 1991 | |
300 | |a 64 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Drugs / Supplement |v 42,2 | |
500 | |a Literaturangaben | ||
650 | 4 | |a Calcium Channel Blockers |x therapeutic use |v Congresses | |
650 | 4 | |a Calcium |x Antagonists |x Therapeutic use |v Congresses | |
650 | 4 | |a Myocardial Infarction |x drug therapy |v Congresses | |
650 | 4 | |a Myocardial Infarction |x prevention & control |v Congresses | |
650 | 4 | |a Myocardial infarction |x Chemotherapy | |
650 | 4 | |a Myocardial infarction |x Prevention | |
650 | 0 | 7 | |a Calciumantagonist |0 (DE-588)4069807-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Sekundärprävention |0 (DE-588)4206691-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Herzinfarkt |0 (DE-588)4024654-1 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Calciumantagonist |0 (DE-588)4069807-5 |D s |
689 | 0 | 1 | |a Herzinfarkt |0 (DE-588)4024654-1 |D s |
689 | 0 | 2 | |a Sekundärprävention |0 (DE-588)4206691-8 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Kelly, David T. |e Sonstige |4 oth | |
810 | 2 | |a Supplement |t Drugs |v 42,2 |w (DE-604)BV000904909 |9 42,2 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-002789799 |
Datensatz im Suchindex
_version_ | 1804118666410721280 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV004530608 |
callnumber-first | R - Medicine |
callnumber-label | RM666 |
callnumber-raw | RM666.C243 |
callnumber-search | RM666.C243 |
callnumber-sort | RM 3666 C243 |
callnumber-subject | RM - Therapeutics and Pharmacology |
ctrlnum | (OCoLC)25176921 (DE-599)BVBBV004530608 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01762nam a2200457 cb4500</leader><controlfield tag="001">BV004530608</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">910930s1991 d||| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)25176921</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004530608</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM666.C243</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Calcium antagonists in secondary prevention</subfield><subfield code="b">augmented proceedings of a symposium held in Stockholm, 21 September, 1990</subfield><subfield code="c">guest ed. D. T. Kelly ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Auckland u.a.</subfield><subfield code="b">Adis Internat.</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">64 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs / Supplement</subfield><subfield code="v">42,2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Calcium Channel Blockers</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Calcium</subfield><subfield code="x">Antagonists</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Myocardial Infarction</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Myocardial Infarction</subfield><subfield code="x">prevention & control</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Myocardial infarction</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Myocardial infarction</subfield><subfield code="x">Prevention</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Calciumantagonist</subfield><subfield code="0">(DE-588)4069807-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sekundärprävention</subfield><subfield code="0">(DE-588)4206691-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herzinfarkt</subfield><subfield code="0">(DE-588)4024654-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Calciumantagonist</subfield><subfield code="0">(DE-588)4069807-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Herzinfarkt</subfield><subfield code="0">(DE-588)4024654-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Sekundärprävention</subfield><subfield code="0">(DE-588)4206691-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kelly, David T.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Drugs</subfield><subfield code="v">42,2</subfield><subfield code="w">(DE-604)BV000904909</subfield><subfield code="9">42,2</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002789799</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV004530608 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:13:55Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002789799 |
oclc_num | 25176921 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
physical | 64 S. graph. Darst. |
publishDate | 1991 |
publishDateSearch | 1991 |
publishDateSort | 1991 |
publisher | Adis Internat. |
record_format | marc |
series2 | Drugs / Supplement |
spelling | Calcium antagonists in secondary prevention augmented proceedings of a symposium held in Stockholm, 21 September, 1990 guest ed. D. T. Kelly ... Auckland u.a. Adis Internat. 1991 64 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Drugs / Supplement 42,2 Literaturangaben Calcium Channel Blockers therapeutic use Congresses Calcium Antagonists Therapeutic use Congresses Myocardial Infarction drug therapy Congresses Myocardial Infarction prevention & control Congresses Myocardial infarction Chemotherapy Myocardial infarction Prevention Calciumantagonist (DE-588)4069807-5 gnd rswk-swf Sekundärprävention (DE-588)4206691-8 gnd rswk-swf Herzinfarkt (DE-588)4024654-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Calciumantagonist (DE-588)4069807-5 s Herzinfarkt (DE-588)4024654-1 s Sekundärprävention (DE-588)4206691-8 s DE-604 Kelly, David T. Sonstige oth Supplement Drugs 42,2 (DE-604)BV000904909 42,2 |
spellingShingle | Calcium antagonists in secondary prevention augmented proceedings of a symposium held in Stockholm, 21 September, 1990 Calcium Channel Blockers therapeutic use Congresses Calcium Antagonists Therapeutic use Congresses Myocardial Infarction drug therapy Congresses Myocardial Infarction prevention & control Congresses Myocardial infarction Chemotherapy Myocardial infarction Prevention Calciumantagonist (DE-588)4069807-5 gnd Sekundärprävention (DE-588)4206691-8 gnd Herzinfarkt (DE-588)4024654-1 gnd |
subject_GND | (DE-588)4069807-5 (DE-588)4206691-8 (DE-588)4024654-1 (DE-588)1071861417 |
title | Calcium antagonists in secondary prevention augmented proceedings of a symposium held in Stockholm, 21 September, 1990 |
title_auth | Calcium antagonists in secondary prevention augmented proceedings of a symposium held in Stockholm, 21 September, 1990 |
title_exact_search | Calcium antagonists in secondary prevention augmented proceedings of a symposium held in Stockholm, 21 September, 1990 |
title_full | Calcium antagonists in secondary prevention augmented proceedings of a symposium held in Stockholm, 21 September, 1990 guest ed. D. T. Kelly ... |
title_fullStr | Calcium antagonists in secondary prevention augmented proceedings of a symposium held in Stockholm, 21 September, 1990 guest ed. D. T. Kelly ... |
title_full_unstemmed | Calcium antagonists in secondary prevention augmented proceedings of a symposium held in Stockholm, 21 September, 1990 guest ed. D. T. Kelly ... |
title_short | Calcium antagonists in secondary prevention |
title_sort | calcium antagonists in secondary prevention augmented proceedings of a symposium held in stockholm 21 september 1990 |
title_sub | augmented proceedings of a symposium held in Stockholm, 21 September, 1990 |
topic | Calcium Channel Blockers therapeutic use Congresses Calcium Antagonists Therapeutic use Congresses Myocardial Infarction drug therapy Congresses Myocardial Infarction prevention & control Congresses Myocardial infarction Chemotherapy Myocardial infarction Prevention Calciumantagonist (DE-588)4069807-5 gnd Sekundärprävention (DE-588)4206691-8 gnd Herzinfarkt (DE-588)4024654-1 gnd |
topic_facet | Calcium Channel Blockers therapeutic use Congresses Calcium Antagonists Therapeutic use Congresses Myocardial Infarction drug therapy Congresses Myocardial Infarction prevention & control Congresses Myocardial infarction Chemotherapy Myocardial infarction Prevention Calciumantagonist Sekundärprävention Herzinfarkt Konferenzschrift |
volume_link | (DE-604)BV000904909 |
work_keys_str_mv | AT kellydavidt calciumantagonistsinsecondarypreventionaugmentedproceedingsofasymposiumheldinstockholm21september1990 |